CTRI/2013/04/003590
Other
Phase 2
A Prospective, multi-centric, single-arm, clinical study toevaluate efficacy and safety of R-TPR-004 in patients undergoing treatment for acute ischemic stroke
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Reliance Life Sciences Pvt Ltd
- Enrollment
- 40
- Status
- Other
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patient with Ischemic Stroke of 4\.5 hours of symptom onset.
- •2\. Patients with normal or slight early CT signs of ischemic stroke.
- •3\. Women of child bearing potential having a negative pregnancy test and taking adequate birth control measures.
- •4\. Consent from Legally Acceptable Representative (LAR), if subject is not in the condition to give consent. However, when the subject is stable and is able to give consent, consent would be obtained on a separate ICF to confirm his/her willingness to continue in the study.
Exclusion Criteria
- •1\. Patient with h/o Recent Stroke \<3 months and/or wake\-up stroke.
- •2\. Patient with h/o Recent MI \<3 weeks.
- •3\. High clinical suspicion of septic embolus.
- •4\. Evidence of acute or chronic ICH by head CT.
- •5\. Persistent hypertension with systolic BP \>185 mmHg or diastolic BP \>110 mmHg (mean of 3 consecutive arm cuff readings over 20\-30 minutes), not controlled by antihypertensive therapy or requiring nitroprusside for control.
- •6\. Presence or h/o intracranial neoplasm or arteriovenous malformation, intracranial aneurysm, unless surgically treated 3 months.
- •7\. Major surgery, serious trauma, lumbar puncture, arterial puncture at a non\-compressible site, or biopsy of a parenchymal organ in last 14 days. (Major surgical procedures include but are not limited to the following: major thoracic or abdominopelvic surgery, neurosurgery, major limb surgery, carotid endarterectomy or other vascular surgery, and organ transplant).
- •8\. Medical history or evidence of HIV, HBV and HCV infection.
- •9\. Subject participation in another clinical trial 30 days prior to administration of IP.
- •10\. Pregnant and lactating females.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective, multi-center, single-arm, clinical investigation of the safety and performance of the Sentio system in users with mixed/conductive hearing losses and single sided deafnessNL-OMON51025Oticon Medical AB15
Recruiting
Not Applicable
A prospective, single arm, multi-center, clinical evaluation of the Ablacath* Mapping Catheter and Ablamap® System utilizing Electrographic Flow (EGF) mapping to resolve extra-pulmonary vein sources Atrial Fibrillation sources and guide ablation therapy.atrial fibrillationirregular heartrhythm10007521NL-OMON56533Cortex Inc.60
Completed
Not Applicable
A Prospective, Multicenter, Single-arm, Clinical Investigation Evaluating the Safety and Performance of GATT-Patch for Hemostasis during Open Liver SurgeryNL-OMON50906GATT Technologies BV47
Completed
Phase 3
A Prospective, Multicenter, Single-arm Clinical Trial of Jetstream Atherectomy System for the Treatment of Japanese Patients with Symptomatic Occlusive Atherosclerotic Lesions in the Superficial Femoral and/ or Proximal Popliteal ArteriesPeripheral Arterial DiseaseJPRN-UMIN000036056Boston Scientific Japan K.K.31
Completed
Phase 4
A prospective, multicentric, single arm clinical study to evaluate the effect of saroGlitazar on non HDL-ChoLesterol in patIents with Diabetic Dyslipidaemia inadequately controllEd with diet, exeRcise and statin.(SAROGLITAZAR)Health Condition 1: E136- Other specified diabetes mellituswith other specified complicationsHealth Condition 2: null- patients with diabetic dyslipidaemia inadequately controlled with diet, exercise and statin.CTRI/2016/08/007126Dr Upendra Kaul104